| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| EXELIXIS, INC. | Director | Common Stock | 42,282 | $1,529,339 | $36.17 | 29 May 2025 | Direct |
| Akero Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $54.31 | 09 Dec 2025 | Direct |
| Invivyd, Inc. | Director | Stock Option (Right to Buy) | 50,000 | 23 May 2023 | Direct | ||
| Xilio Therapeutics, Inc. | Director | Stock Option (right to buy) | 13,200 | 12 Jun 2023 | Direct | ||
| Akero Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 0 | 09 Dec 2025 | Direct | ||
| OptiNose, Inc. | Director | Stock Option (Right to Buy) | 0 | 21 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AKRO | Akero Therapeutics, Inc. | 09 Dec 2025 | 5 | $0 | 4 | Director | 09 Dec 2025, 10:26 |
| AKRO | Akero Therapeutics, Inc. | 03 Jun 2025 | 1 | $0 | 4 | Director | 05 Jun 2025, 16:05 |
| EXEL | EXELIXIS, INC. | 29 May 2025 | 1 | $0 | 4 | Director | 30 May 2025, 19:14 |
| EXEL | EXELIXIS, INC. | 21 May 2025 | 1 | -$201,254 | 4 | Director | 22 May 2025, 19:25 |
| OPTN | OptiNose, Inc. | 21 May 2025 | 5 | $0 | 4 | Director | 21 May 2025, 09:23 |
| AKRO | Akero Therapeutics, Inc. | 08 Jun 2024 | 1 | $0 | 4 | Director | 11 Jun 2024, 17:25 |
| OPTN | OptiNose, Inc. | 06 Jun 2024 | 1 | $0 | 4 | Director | 07 Jun 2024, 16:23 |
| EXEL | EXELIXIS, INC. | 31 May 2024 | 1 | $0 | 4 | Director | 04 Jun 2024, 20:20 |
| AKRO | Akero Therapeutics, Inc. | 23 Jun 2023 | 1 | $0 | 4 | Director | 27 Jun 2023, 17:52 |
| AKRO | Akero Therapeutics, Inc. | 16 Jun 2023 | 3 | -$770,489 | 4 | Director | 21 Jun 2023, 17:54 |
| XLO | Xilio Therapeutics, Inc. | 12 Jun 2023 | 1 | $0 | 4 | Director | 13 Jun 2023, 16:30 |
| OPTN | OptiNose, Inc. | 08 Jun 2023 | 1 | $0 | 4 | Director | 09 Jun 2023, 14:03 |
| EXEL | EXELIXIS, INC. | 31 May 2023 | 2 | $0 | 4 | Director | 02 Jun 2023, 21:51 |
| EXEL | EXELIXIS, INC. | 31 May 2023 | 0 | $0 | 3 | Director | 02 Jun 2023, 21:50 |
| IVVD | Invivyd, Inc. | 23 May 2023 | 1 | $0 | 4 | Director | 25 May 2023, 18:46 |
| XLO | Xilio Therapeutics, Inc. | 15 Sep 2022 | 0 | $0 | 3 | Director | 16 Sep 2022, 16:50 |
| XLO | Xilio Therapeutics, Inc. | 15 Sep 2022 | 1 | $0 | 4 | Director | 16 Sep 2022, 16:15 |
| IVVD | Adagio Therapeutics, Inc. | 22 Jun 2022 | 1 | $0 | 4 | Director | 24 Jun 2022, 16:31 |
| OPTN | OptiNose, Inc. | 08 Jun 2022 | 1 | $0 | 4 | Director | 09 Jun 2022, 10:24 |
| AKRO | Akero Therapeutics, Inc. | 02 Jun 2022 | 1 | $0 | 4 | Director | 03 Jun 2022, 16:06 |
| IVVD | Adagio Therapeutics, Inc. | 05 Aug 2021 | 0 | $0 | 3 | Director | 05 Aug 2021, 21:22 |
| OPTN | OptiNose, Inc. | 09 Jun 2021 | 1 | $0 | 4 | Director | 10 Jun 2021, 15:15 |
| AKRO | Akero Therapeutics, Inc. | 01 Jun 2021 | 1 | $0 | 4 | Director | 03 Jun 2021, 17:59 |